Table 1E.
Country (region) | Population (in millions) | COVID-19 cases per million (in thousands) | Deaths due to COVID-19 (per million) |
Wave with more impact on the country | Wave with more impact on NBS | Average number of newborns per country (2015–2020; from 30 June of the initial and final year) | Newborns screened/year/centre | Number of diseases in NBS | Impairment of NBS during the pandemic* | Were there plans/guidelines for NBS during a pandemic |
North and Central America | ||||||||||
Canada (Nova Scotia) | 38.1 | 32.5 | 639 | Both equally | Both equally | 385 533 | 17 000 | 21–30 | Little | No |
Canada (Alberta) | 38.1 | 32.5 | 639 | Second | N/A | 385 533 | 55 000 | 21–30 | Little | N/A |
USA (Texas) | 332.6 | 99.8 | 1777 | Second | Second | 3 900 750 | 0† | 31 or more | Moderate | No |
USA (San Diego, California) | 332.6 | 99.8 | 1777 | Both equally | Both equally | 3 900 750 | 85 000 | 31 or more | N/A | N/A |
*A 5-point Likert scale was used to determine the impairment (1=none, 2=little, 3=moderate, 4=a lot, 5=a great deal).
†0 newborn screened by the state. They are followed up by volunteer consultants.
N/A, not available; NBS, newborn screening.